Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,446 | -4,588 | -2,301 | -8,052 | -4,705 |
| Depreciation Amortization | 272 | 181 | 90 | 367 | 278 |
| Other Working Capital | -448 | -119 | -60 | -150 | -14 |
| Other Operating Activity | -97 | -28 | -96 | -1,006 | -2,258 |
| Operating Cash Flow | $-6,719 | $-4,554 | $-2,366 | $-8,841 | $-6,699 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | -34 | -26 | -30 | -17 |
| Investing Cash Flow | $-40 | $-34 | $-26 | $-30 | $-17 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 4,618 | 4,618 |
| Debt Repayment | -62 | -2 | -1 | -619 | -619 |
| Common Stock Issued | N/A | N/A | N/A | 12,396 | 12,396 |
| Other Financing Activity | -130 | 0 | 0 | -520 | -520 |
| Financing Cash Flow | $-192 | $-2 | $-1 | $15,874 | $15,874 |
| Beginning Cash Position | 9,423 | 9,423 | 9,423 | 2,418 | 2,418 |
| End Cash Position | 2,473 | 4,833 | 7,030 | 9,423 | 11,576 |
| Net Cash Flow | $-6,950 | $-4,589 | $-2,393 | $7,004 | $9,158 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,719 | -4,554 | -2,366 | -8,841 | -6,699 |
| Capital Expenditure | -40 | -34 | -26 | -30 | -17 |
| Free Cash Flow | -6,758 | -4,587 | -2,392 | -8,870 | -6,717 |